Suppression of Postprandial Monocyte Activation by Blueberries or Docosahexaenoic Acid in Humans
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 60 |
| Updated: | 11/1/2018 |
| Start Date: | June 2015 |
| End Date: | November 2017 |
Suppression of Postprandial Monocyte Activation by Fruit Rich in Anti-inflammatory Polyphenols or Docosahexaenoic Acid in Humans
The overall goal of the research study is to determine whether a high-fat meal causes
postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids
(PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the
inflammation in healthy people.
postprandial (after meal) inflammation, and whether eating n-3 polyunsaturated fatty acids
(PUFAs) or blueberries that are rich in anti-inflammatory polyphenols suppress the
inflammation in healthy people.
Chronic inflammation is one of the key etiological conditions associated with the development
and progression of chronic diseases including Alzheimer's disease, atherosclerotic
cardiovascular disease, insulin resistance, obesity and cancer. The causes of chronic
inflammation and the role of diet in suppressing inflammation are challenging research
questions. Pattern recognition receptors (PRRs), including Toll-like receptors (TLRs),
nucleotide-binding oligomerization domain proteins (NODs), and the inflammasome expressed in
innate immune cells can be activated by a variety of endogenous molecules derived from tissue
injury and diet (in particular saturated fatty acids), eliciting inflammation. Dysregulated
induction of PRR-mediated inflammation is known to promote the development of chronic
diseases. Previous studies showed that saturated fatty acids can activate toll-like receptor
4 (TLR4) and nucleotide-binding oligomerization domain 2 (NOD2) mediated signaling pathways,
whereas, docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, and certain
polyphenols (quercetin, luteolin, Epigallocatechin gallate (EGCG), resveratrol) rich in
certain fruits and vegetables inhibit TLR4 or NOD2-mediated inflammation. In addition,
numerous studies have demonstrated that TLR4 knockout mice were protected from high saturated
fat diet-induced inflammation and insulin resistance, suggesting that high fat diet-induced
inflammation and insulin resistance are at least partly mediated through the activation of
TLR4. Direct evidence of saturated fatty acids derived from a high fat meal activating PRRs
in humans has not been demonstrated. Thus, the investigators propose to determine whether
saturated fatty acids derived from a high saturated fat meal activate blood monocytes through
PRRs and whether dietary DHA and freeze-dried blueberry powder can suppress high saturated
fat meal-induced inflammation by inhibiting PRR activation.
The experimental procedures and the study activities will last for approximately 9 weeks.
There will be three test days, scheduled 4 weeks apart. On the test days there will be four
blood draws (one fasting blood draw and three postprandial blood draws at 1-hour, 3-hour and
6-hour after breakfast, respectively). Three endothelial function measurements (EndoPAT) will
be carried out each test day. A pre-test dinner meal will be provided to the subject to eat
the night before each test day. Subjects will be asked to follow and record a low antioxidant
and polyphenol diet of their own choosing for 3 days prior to each test day. This includes
minimizing tea, wine, coffee, chocolate, fruits, vegetables, whole grains, soy, herbs,
spices, condiments, and fatty fish. All volunteers will participate in all test days,
receiving in randomize cross-over fashion the following treatments:
A. High saturated fat diet, placebo powder, sunflower oil. B. High saturated fat diet,
blueberry powder, sunflower oil. C. High saturated fat diet, placebo powder, DHA.
The high saturated fat meal will be identical in all treatments and may contain tortilla,
cheddar cheese, beef sausage, scrambled eggs, and a smoothie style drink containing sugar,
vanilla extract, oil, whole milk yogurt and the ingredients for masking treatments. The
placebo powder may contain Beneprotein® (Nestlé Nutrition), Benefiber® (Novartis), oil,
sugar, artificial food-grade blueberry flavor, and artificial food-grade blue and red colors.
The blueberry powder (equivalent to four 1/2 cup servings) will be obtained from the U.S.
Highbush Blueberry Council (Folsom, CA). The DHA will be obtained from Martek Biosciences.
Blueberry or placebo powder and the DHA or sunflower oil will be combined into a blueberry
flavored smoothie style drink. Neither the study subjects or the investigators will know
which treatment is provided on which test day.
and progression of chronic diseases including Alzheimer's disease, atherosclerotic
cardiovascular disease, insulin resistance, obesity and cancer. The causes of chronic
inflammation and the role of diet in suppressing inflammation are challenging research
questions. Pattern recognition receptors (PRRs), including Toll-like receptors (TLRs),
nucleotide-binding oligomerization domain proteins (NODs), and the inflammasome expressed in
innate immune cells can be activated by a variety of endogenous molecules derived from tissue
injury and diet (in particular saturated fatty acids), eliciting inflammation. Dysregulated
induction of PRR-mediated inflammation is known to promote the development of chronic
diseases. Previous studies showed that saturated fatty acids can activate toll-like receptor
4 (TLR4) and nucleotide-binding oligomerization domain 2 (NOD2) mediated signaling pathways,
whereas, docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, and certain
polyphenols (quercetin, luteolin, Epigallocatechin gallate (EGCG), resveratrol) rich in
certain fruits and vegetables inhibit TLR4 or NOD2-mediated inflammation. In addition,
numerous studies have demonstrated that TLR4 knockout mice were protected from high saturated
fat diet-induced inflammation and insulin resistance, suggesting that high fat diet-induced
inflammation and insulin resistance are at least partly mediated through the activation of
TLR4. Direct evidence of saturated fatty acids derived from a high fat meal activating PRRs
in humans has not been demonstrated. Thus, the investigators propose to determine whether
saturated fatty acids derived from a high saturated fat meal activate blood monocytes through
PRRs and whether dietary DHA and freeze-dried blueberry powder can suppress high saturated
fat meal-induced inflammation by inhibiting PRR activation.
The experimental procedures and the study activities will last for approximately 9 weeks.
There will be three test days, scheduled 4 weeks apart. On the test days there will be four
blood draws (one fasting blood draw and three postprandial blood draws at 1-hour, 3-hour and
6-hour after breakfast, respectively). Three endothelial function measurements (EndoPAT) will
be carried out each test day. A pre-test dinner meal will be provided to the subject to eat
the night before each test day. Subjects will be asked to follow and record a low antioxidant
and polyphenol diet of their own choosing for 3 days prior to each test day. This includes
minimizing tea, wine, coffee, chocolate, fruits, vegetables, whole grains, soy, herbs,
spices, condiments, and fatty fish. All volunteers will participate in all test days,
receiving in randomize cross-over fashion the following treatments:
A. High saturated fat diet, placebo powder, sunflower oil. B. High saturated fat diet,
blueberry powder, sunflower oil. C. High saturated fat diet, placebo powder, DHA.
The high saturated fat meal will be identical in all treatments and may contain tortilla,
cheddar cheese, beef sausage, scrambled eggs, and a smoothie style drink containing sugar,
vanilla extract, oil, whole milk yogurt and the ingredients for masking treatments. The
placebo powder may contain Beneprotein® (Nestlé Nutrition), Benefiber® (Novartis), oil,
sugar, artificial food-grade blueberry flavor, and artificial food-grade blue and red colors.
The blueberry powder (equivalent to four 1/2 cup servings) will be obtained from the U.S.
Highbush Blueberry Council (Folsom, CA). The DHA will be obtained from Martek Biosciences.
Blueberry or placebo powder and the DHA or sunflower oil will be combined into a blueberry
flavored smoothie style drink. Neither the study subjects or the investigators will know
which treatment is provided on which test day.
Inclusion Criteria:
- Body Mass Index of 18-25 kg/m2
- Complete Blood Count (CBC) within normal limits
- Blood chemistry panel within normal limits
Exclusion Criteria:
- following a vegetarian diet
- smoke or use tobacco products
- consume more than one alcoholic beverage per day (defined as 1 oz. distilled liquor, 3
oz. wine, or 12 oz. beer)
- taking any cholesterol lowering
- taking blood pressure medication
- taking non-steroidal anti-inflammatory drugs (NSAIDS) more than once a week and for 3
days before each test day
- taking steroids for asthma or other inflammatory states
- taking thyroid-regulating drugs
- taking over-the-counter weight loss products
- allergies or sensitivities to foods or ingredients in the test meals, especially
blueberries or DHA
- taking fish or algae oil or other dietary supplements and unwilling to stop the
supplements for the duration of the study (multivitamin is OK)
- Women who are pregnant, lactating or planning a pregnancy
- fasting blood cholesterol greater than 240 mg/dL
- fasting blood triglyceride greater than 300mg/dL
- hemoglobin less than 11.5 mg/dL
- blood pressure greater than 140/90 mmHg
- metabolic diseases such as diabetes mellitus, hypothyroidism, kidney disease, liver
disease, bleeding disorders, autoimmune diseases, other inflammatory disease, or
cancer unless greater than 5 years remission
We found this trial at
1
site
Click here to add this to my saved trials
